Array Comparative Genomic Hybridisation (CGH)



Similar documents
Fluorescence in situ hybridisation (FISH)

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.

Fact Sheet 14 EPIGENETICS

About The Causes of Hearing Loss

X Linked Inheritance

Balanced. translocations. rarechromo.org. Support and Information

Each person normally has 23 pairs of chromosomes, or 46 in all. We inherit one chromosome per pair from our mother and one from our father.

Genetic Testing in Research & Healthcare

APPENDIX B SAMPLE INFORMED CONSENT FORM

Trisomy 13 (also called Patau s syndrome or T13)

Information leaflet. Centrum voor Medische Genetica. Version 1/ Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel

Overview of Genetic Testing and Screening

BRCA1 and BRCA2 for men

Usher Syndrome Genetics

Patient Information. for Childhood

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)

Breast cancer and genetics

Marrying a relative. Is there an increased chance that a child will have genetic problems if its parents are related to each other?

Taking Part in Research at University Hospitals Birmingham

How does genetic testing work?

Prenatal screening and diagnostic tests

Executive summary. Current prenatal screening

BRCA1 & BRCA2 GeneHealth UK

If you are signing for a minor child, you refers to your child throughout the consent document.

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

Life Insurance. What you need to know about. Mucopolysaccharide and related diseases including Fabry disease

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

A test your patients can trust.

Ultrasound scans in pregnancy

RhD Negative and care in pregnancy

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

PROVIDER POLICIES & PROCEDURES

In recent years the number of DNA genetic tests that you can

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Why does my child have a hearing loss?

Robertsonian Translocations

First Trimester Screening for Down Syndrome

REI Pearls: Pitfalls of Genetic Testing in Miscarriage


your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing.

Automated DNA sequencing 20/12/2009. Next Generation Sequencing

12.1 The Role of DNA in Heredity

CONSENT FORM. Cord Blood Banking for Transplantation

Genetics for the Novice

PARTICIPANT INFORMATION

CCR Biology - Chapter 7 Practice Test - Summer 2012

ARMENIA. Albert Matevosyan MD,PhD

MUSCLE BIOPSY FREQUENTLY ASKED QUESTIONS. for mitochondrial and metabolic disorders

The Genetics of Beckwith Wiedemann Syndrome (BWS)

Patient Demographic Form

Integration of Genetic and Familial Data into. Electronic Medical Records and Healthcare Processes

Reproductive Technology. Chapter 21

A trait is a variation of a particular character (e.g. color, height). Traits are passed from parents to offspring through genes.

A Guide to Prenatal Genetic Testing

14.3 Studying the Human Genome

Mitochondrial DNA Analysis

UNIT 13 (OPTION) Genetic Abnormalities

Sexual Reproduction. The specialized cells that are required for sexual reproduction are known as. And come from the process of: GAMETES

Mycophenolate mofetil (CellCept ): risks of miscarriage and birth defects. Patient guide. Key points to remember

User guide for referring samples to the IBGRL Molecular Diagnostics Laboratory

Prenatal Testing Special tests for your baby during pregnancy

1. Why is mitosis alone insufficient for the life cycle of sexually reproducing eukaryotes?

Hereditary Breast and Ovarian Cancer (HBOC)

Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait

Influence of Sex on Genetics. Chapter Six

Neural tube defects (NTDs): open spina bifida (also called spina bifida cystica)

Eating Disorders Outpatient Treatment

PARTNERS IN PEDIATRIC CARE. Intake and History for Mental Health Referral

Intensive Positive Behaviour Support Service (ipbs)

The correct answer is c A. Answer a is incorrect. The white-eye gene must be recessive since heterozygous females have red eyes.

Patient Information. Ordering Physician Information. Indication for Testing (REQUIRED)

Genetics and Pregnancy Loss

Cancer Genomics: What Does It Mean for You?

Consent Form: Example 2 (DNA Sequencing)

Chromosomes, Mapping, and the Meiosis Inheritance Connection

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders

Stonebridge Adult Medicine, P.A. Registration Form (Please Print)

Basics of Marker Assisted Selection

Carrier detection tests and prenatal diagnosis

Nevada Department of Education Standards

Patient Information Leaflet: Part 1 select-d

Biology Behind the Crime Scene Week 4: Lab #4 Genetics Exercise (Meiosis) and RFLP Analysis of DNA

CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY

Instructions for 24 hr Urine Collection

The Liver and Alpha-1. Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION

MCB41: Second Midterm Spring 2009

CHROMOSOME STRUCTURE CHROMOSOME NUMBERS

Oesophageal stent insertion

Transcription:

Array Comparative Genomic Hybridisation (CGH) Exceptional healthcare, personally delivered

What is array CGH? Array CGH is a new test that is now offered to all patients referred with learning disability and to some patients with other physical problems. Using array CGH, the laboratory is able to look at thousands of separate sections of your child s DNA (which contains the genes). This shows whether sections of DNA are either missing or present in extra copies. Missing pieces (loss) or extra copies (gain) of genetic material may lead to clinical problems such as learning disability and some physical problems. The main benefit of array CGH is that it is able to detect much smaller genetic changes than was previously possible. Array CGH can also provide very accurate information on the size and the possible effects of the genetic changes found. Array CGH testing on your child will only be done with your consent. What are genes? Genes are the blueprint of the body. When one or more genes are lost or gained the blueprint is changed. This can lead to clinical problems from birth such as learning difficulties and some physical problems. Genes are made of a chemical called DNA and contained inside larger structures called chromosomes. Most people have 23 pairs of chromosomes (46 in total). One of each pair comes from the mother and the other from the father. Chromosomes are numbered 1 (the largest pair) to 22 (the smallest pair). The 23rd pair (X and Y) are called sex chromosomes because they determine whether a person is male or female. Each chromosome has a q arm (which is long) and a p arm (which is short). The genes are arranged in groups clusters along these arms (like beads on a string). 2 Array Comparative Genomic Hybridisation (CGH)

What happens when my child s blood is sent for array CGH testing? Two tubes from the same blood test are sent to the laboratory. DNA is extracted from one tube and the laboratory stores cells from the other. This is in case more tests are needed after the array CGH result is known. The array test is technically quite complex and in a small number of cases may simply fail to work, in which case a repeat sample may be asked for. The array CGH test normally takes four to six weeks to report. In three quarters of cases the laboratory will not find a problem and will issue a normal report to your doctor. Your doctor may then want to begin other tests. What does a normal result mean? A normal result means that the laboratory has not found a problem with your child s DNA. Having a normal result will not always rule out a particular problem. A normal array CGH result also provides useful information. After a normal result your doctor may begin further tests. What happens if array CGH finds something? In around one quarter of cases, array CGH will reveal missing or extra genetic material. Many of the changes found by array CGH have a well known pattern of medical problems. Your doctor will discuss the results with you to help you to fully understand them. You may also be offered a consultation at your local Clinical Genetics service. Some array CGH results are very rare or may never have been seen before. In these cases, it may not be possible to work out if a particular array CGH result will cause a problem, or what medical problems may be expected. Array Comparative Genomic Hybridisation (CGH) 3

1. You consult your local doctor 2. Two tubes of your child s blood are sent to the laboratory 3. Array CGH is carried out by the laboratory 4. The laboratory issues a report OR 5. A normal report goes to your doctor 5. The laboratory issues a preliminary report 6. Your doctor sends blood from the mother and father to the lab 7. Lab issues a final report 8. Referral to the Clinical Genetics service may be offered 9. The array CGH result is explained and action plans for future treatment or testing are discussed 4 Array Comparative Genomic Hybridisation (CGH)

At this stage the laboratory will issue a Preliminary Report to your doctor. This report will give details of the genetic change and will ask for samples from both parents. Testing both mother and father to look for the same genetic change can sometimes help understand this type of uncertain result. Testing parents If an uncertain result is found, your doctor will ask both parents to give a blood sample. This will be sent to the laboratory for further testing to help them to understand your child s results. It is very important for the laboratory to receive blood samples from both parents. If you know that one parent will not be available for testing, please tell your doctor as soon as possible. The mother s and father s samples will be tested to see if either parent is carrying the genetic change seen in your child. The blood tests on the parents will only be looking for the change seen in their child. If the genetic change seen in your child is not found in the mother or father then it is likely that this change is the cause of your child s clinical problems. Final Report When the parental tests have been completed, the laboratory will issue a Final Report. This is based upon what has been found in your child s array CGH and the results of parental testing. This will be discussed with you to help you to fully understand the results. It is sometimes found that your child s genetic change is normal human variation and is not the cause of your child s clinical problems. Once the final report has been issued you may be offered a consultation at your local Clinical Genetics service. Array Comparative Genomic Hybridisation (CGH) 5

Unexpected findings In very rare cases, the array CGH test may find a genetic change which may be clinically important but may not be directly related to your child s current problems. In the very unlikely event that an unexpected result is found, this will be fully explained during a consultation with your local Clinical Genetics service. What happens to the sample after testing? The blood samples and stored cells are routinely discarded after testing is completed. DNA is very stable and is stored indefinitely by the laboratory (or until it runs out). Genetics is a rapidly developing field. It is possible to test DNA for a number of genetic conditions, with more tests becoming available each year. Storing DNA lets us to carry out any relevant tests in the future without taking a further sample. However, if requested, we will make sure that the DNA is discarded after testing. 6 Array Comparative Genomic Hybridisation (CGH)

References and further information The Bristol Genetics Laboratory www.nbt.nhs.uk [Last Accessed March 2012] The rare chromosome disorders charity Unique www.rarechromo.org [Last Accessed March 2012]. Unique offers support and information to all families affected by rare chromosome disorders Microarray-based comparative genomic hybridisation (array CGH) information leaflet produced by Unique (http:// www.rarechromo.org/forum/disordersleaflets.asp) Miller D et al (2010). Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;14;86(5):749-64 NHS Constitution. Information on your rights and responsibilities. Available at www.nhs.uk/aboutnhs/ constitution Array Comparative Genomic Hybridisation (CGH) 7

How to contact us: See your appointment letter for the number to phone with any queries you may have www.nbt.nhs.uk/genetics If you or the individual you are caring for need support reading this leaflet please ask a member of staff for advice. North Bristol NHS Trust. This edition published May 2014. Review due May 2016. NBT002584